AIM
MIRM icon

AXA Investment Managers’s Mirum Pharmaceuticals MIRM Stock Holding History

AXA Investment Managers’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$18.7M Buy
+255,688
New +$16.3M 0.05% 295

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

AXA Investment Managers's MIRM Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2025: 255,688 shares worth $18.7M. The stake represents 0.05% of the portfolio and ranks #295 among its holdings.

272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

  • AXA Investment Managers held 255,688 shares of Mirum Pharmaceuticals worth $18.7M as of Q3 2025.
  • Mirum Pharmaceuticals was a new AXA Investment Managers position in Q3 2025.
  • Mirum Pharmaceuticals made up 0.05% of AXA Investment Managers's portfolio in Q3 2025, its #295 holding.
  • 272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.